Rational Protocol Design for Cell Therapy
Regenerative Medicine
Research/Pre-clinicalActive
Key Facts
About Cellular Intelligence
Cellular Intelligence is developing a foundational AI model to predict and simulate how cells respond to external signals, addressing the core challenge of context-dependent cellular behavior. The company leverages a proprietary, high-throughput data generation platform and a world-class scientific team to train transformer models on massive-scale perturbation datasets. Its long-term goal is to create a universal simulation engine that can rationally design protocols for regenerative medicine, predict drug effects, and model diseases, thereby accelerating therapeutic discovery.
View full company profileTherapeutic Areas
Other Regenerative Medicine Drugs
| Drug | Company | Phase |
|---|---|---|
| Undisclosed Regenerative Medicine Program(s) | Cell BioEngines | Pre-clinical |
| Pluristyx Partnership (iPSC-MSC Banks) | Stemmatters | Development |
| Accelerated Biosciences Collaboration (Trophoblast iPSC) | Stemmatters | Development |
| Undisclosed Program | CRISPR Therapeutics | Preclinical |